Zejula (niraparib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Zejula (niraparib), covering 2025-09-29 to 2025-09-29. Get the full timeline:
Most recent: Clinical Trial Update: A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study [Phase 2]